跳至主要内容
临床试验/NCT01889017
NCT01889017Unknown不适用

Generic Immunosuppressive Drugs After Lung Transplantation - a Crosssectional Observational Study by Patient Questionnaire

Hannover Medical School1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2013年7月最近更新:
适应症

试验速览

阶段
不适用
入组人数
600
试验地点
1
主要终点
Frequency of use of generic immunosuppressive drugs

研究概览

简要总结

Extent of use of generics immunosuppressive drugs in clinical practice after lung transplantation

详细描述

Solid organ transplant recipients are treated with immunosuppressive drugs to prevent rejection of their grafts. The most frequently important maintenance immunosuppressive drugs in Europe are calcineurin inhibitors.

For a number of these compounds drug patents have expired in recent years and generic formulations have entered the market. There is considerable debate regarding the efficacy and safety of generic drug substitution in solid organ recipients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients after lung transplantation (single, double or combined)
  • informed consent
  • patient with an immunosuppressive therapy with tacrolimus or ciclosporin

排除标准

  • immunosuppressive therapy without calcineurin inhibitors
  • need for isolation (Colonization with multi. or pan resistant organisms e.g. methicillin-resistant staph. aureus[MRSA), B. cenocepacia)
  • limited German language skills or other reasons which might impair patient communication or computer handling

结局指标

主要结局

Frequency of use of generic immunosuppressive drugs

时间窗: baseline

次要结局

  • Calcineurin inhibitor through levels(baseline, retrospective 6 months)
  • Dose of calcineurin inhibitors(baseline)
  • Therapy adherence(baseline)
  • Satisfaction with immunosuppression(baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Thomas Fuehner

MD

Hannover Medical School

研究点 (1)

Loading locations...

相似试验